Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sofia Grigoriadou

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Rheumatology|December 17, 2021
Severity of COVID-19 infection in primary Sjögren's syndrome and the emerging evidence of COVID-19-induced xerostomiaFarzana Chowdhury, Sofia Grigoriadou, Michele Bombardieri
Frontiers in Immunology|February 15, 2021
Does the Lectin Complement Pathway Link Kawasaki Disease and SARS-CoV-2?Anastasia Polycarpou, Sofia Grigoriadou, Linda Klavinskis, et al.
Clinical Medicine (London, England)|February 5, 2015
Lesson of the month 2: The limitations of steroid therapy in bradykinin-mediated angioedema attacksSharif Ismail, Leo Cheng, Sofia Grigoriadou, et al.
Expert Review of Clinical Immunology|April 2, 2014
Secondary antibody deficiencySai S Duraisingham, Matthew S Buckland, Sofia Grigoriadou, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 26, 2014
Acquired C1 inhibitor deficiency: should we monitor for associated antibody deficiency?Arun Tohani, Ignatius Chua, Sofia Grigoriadou, et al.
European Journal of Microbiology & Immunology|December 30, 2014
Pseudomonas infection in antibody deficient patientsSai S Duraisingham, Steven Hanson, Matthew Buckland, et al.
Journal of Clinical Pathology|October 8, 2021
Measurement of C1-Inhibitor function alone is sufficient for diagnosis of hereditary angioedemaSorena Kiani-Alikhan, Elizabeth Walker, Alaco Hickey, et al.
Clinical and Experimental Rheumatology|August 30, 2019
B cell depletion with rituximab in the treatment of primary Sjögren's syndrome: what have we learnt?Sofia Grigoriadou, Farzana Chowdhury, Elena Pontarini, et al.
European Journal of Dermatology : EJD|February 22, 2014
Use of recombinant C1 inhibitor in patients with resistant or frequent attacks of hereditary or acquired angioedemaAnia L Manson, John Dempster, Sofia Grigoriadou, et al.
Plos One|June 28, 2014
Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacementSai S Duraisingham, Matthew Buckland, John Dempster, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Rheumatology|December 17, 2021
Severity of COVID-19 infection in primary Sjögren's syndrome and the emerging evidence of COVID-19-induced xerostomiaFarzana Chowdhury, Sofia Grigoriadou, Michele Bombardieri
Frontiers in Immunology|February 15, 2021
Does the Lectin Complement Pathway Link Kawasaki Disease and SARS-CoV-2?Anastasia Polycarpou, Sofia Grigoriadou, Linda Klavinskis, et al.
Clinical Medicine (London, England)|February 5, 2015
Lesson of the month 2: The limitations of steroid therapy in bradykinin-mediated angioedema attacksSharif Ismail, Leo Cheng, Sofia Grigoriadou, et al.
Expert Review of Clinical Immunology|April 2, 2014
Secondary antibody deficiencySai S Duraisingham, Matthew S Buckland, Sofia Grigoriadou, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 26, 2014
Acquired C1 inhibitor deficiency: should we monitor for associated antibody deficiency?Arun Tohani, Ignatius Chua, Sofia Grigoriadou, et al.
European Journal of Microbiology & Immunology|December 30, 2014
Pseudomonas infection in antibody deficient patientsSai S Duraisingham, Steven Hanson, Matthew Buckland, et al.
Journal of Clinical Pathology|October 8, 2021
Measurement of C1-Inhibitor function alone is sufficient for diagnosis of hereditary angioedemaSorena Kiani-Alikhan, Elizabeth Walker, Alaco Hickey, et al.
Clinical and Experimental Rheumatology|August 30, 2019
B cell depletion with rituximab in the treatment of primary Sjögren's syndrome: what have we learnt?Sofia Grigoriadou, Farzana Chowdhury, Elena Pontarini, et al.
European Journal of Dermatology : EJD|February 22, 2014
Use of recombinant C1 inhibitor in patients with resistant or frequent attacks of hereditary or acquired angioedemaAnia L Manson, John Dempster, Sofia Grigoriadou, et al.
Plos One|June 28, 2014
Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacementSai S Duraisingham, Matthew Buckland, John Dempster, et al.
Pageof 4